BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20504322)

  • 21. Serum Protein Markers for the Early Detection of Lung Cancer: A Focus on Autoantibodies.
    Broodman I; Lindemans J; van Sten J; Bischoff R; Luider T
    J Proteome Res; 2017 Jan; 16(1):3-13. PubMed ID: 27769114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical relevance of autoantibody detection in lung cancer.
    Solassol J; Maudelonde T; Mange A; Pujol JL
    J Thorac Oncol; 2011 May; 6(5):955-62. PubMed ID: 21415775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers.
    Rom WN; Goldberg JD; Addrizzo-Harris D; Watson HN; Khilkin M; Greenberg AK; Naidich DP; Crawford B; Eylers E; Liu D; Tan EM
    BMC Cancer; 2010 May; 10():234. PubMed ID: 20504322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
    Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
    Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
    Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
    Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer.
    Wang P; Qin J; Ye H; Li L; Wang X; Zhang J
    J Cell Biochem; 2019 Mar; 120(3):3091-3100. PubMed ID: 30484895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
    Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
    Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survey of autoantibody responses against tumor-associated antigens in thyroid cancer.
    Abols A; Ducena K; Zayakin P; Silina K; Kalnina Z; Sadovska L; Tars J; Vilmanis J; Narbuts Z; Eglitis J; Pirags V; Line A
    Cancer Biomark; 2014; 14(5):361-9. PubMed ID: 25171478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating anti-p53 antibodies in lung cancer and relationship to histology and smoking.
    Yongliang Li Paul W Brandt-Rauf Walter P Carney Donald Y Tenney Jean G Ford
    Biomarkers; 1999; 4(5):381-90. PubMed ID: 23902358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera.
    Qiu J; Choi G; Li L; Wang H; Pitteri SJ; Pereira-Faca SR; Krasnoselsky AL; Randolph TW; Omenn GS; Edelstein C; Barnett MJ; Thornquist MD; Goodman GE; Brenner DE; Feng Z; Hanash SM
    J Clin Oncol; 2008 Nov; 26(31):5060-6. PubMed ID: 18794547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies in lung cancer: possibilities for early detection and subsequent cure.
    Chapman CJ; Murray A; McElveen JE; Sahin U; Luxemburger U; Türeci O; Wiewrodt R; Barnes AC; Robertson JF
    Thorax; 2008 Mar; 63(3):228-33. PubMed ID: 17932110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Profiling tumor-associated antibodies for early detection of non-small cell lung cancer.
    Zhong L; Coe SP; Stromberg AJ; Khattar NH; Jett JR; Hirschowitz EA
    J Thorac Oncol; 2006 Jul; 1(6):513-9. PubMed ID: 17409910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma.
    Chen G; Wang X; Yu J; Varambally S; Yu J; Thomas DG; Lin MY; Vishnu P; Wang Z; Wang R; Fielhauer J; Ghosh D; Giordano TJ; Giacherio D; Chang AC; Orringer MB; El-Hefnawy T; Bigbee WL; Beer DG; Chinnaiyan AM
    Cancer Res; 2007 Apr; 67(7):3461-7. PubMed ID: 17409457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival of patients with stage I lung cancer detected on CT screening.
    ; Henschke CI; Yankelevitz DF; Libby DM; Pasmantier MW; Smith JP; Miettinen OS
    N Engl J Med; 2006 Oct; 355(17):1763-71. PubMed ID: 17065637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression of airway dysplasia and C-reactive protein in smokers at high risk of lung cancer.
    Sin DD; Man SF; McWilliams A; Lam S
    Am J Respir Crit Care Med; 2006 Mar; 173(5):535-9. PubMed ID: 16339918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma.
    Himoto T; Kuriyama S; Zhang JY; Chan EK; Kimura Y; Masaki T; Uchida N; Nishioka M; Tan EM
    Int J Oncol; 2005 Oct; 27(4):1079-85. PubMed ID: 16142326
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.